triple hormone receptor agonist retatrutide gip glp-1 glucagon phase 3 2025 Dual and Gut Peptide Agonists on Media Centre | EASD

Hydration Requirements Retatrutide can reduce thirst perception while simultaneously causing fluid loss through increased urination and potential GI effects

You should seek medical attention immediately if you experience any of the following: ongoing abdominal pain, with or without vomiting swelling of your eyes, face, mouth, tongue, or throat difficulty breathing or swallowing swelling of your legs, ankles, or feet vision changes fainting or dizziness yellowing of your skin or eyes clay-colored stools rapid heartbeat confusion or drowsiness blurred vision slurred speech Semaglutide is typically considered safe but should be used only if you have a prescription from a healthcare professional

This is often when the metabolic benefits of the medication are most visible

Why combining makes sense Insulin and GLP-1 receptor agonists are complementary